Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Biocryst Pharmaceuticals buy Evercore Inc.

Start price
€6.00
18.02.26 / 50%
Target price
€14.35
18.02.27
Performance (%)
5.27%
Price
€6.32
22:26
Summary
This prediction is currently active. With a performance of 5.27%, the BUY prediction by Evercore_Inc_ for Biocryst Pharmaceuticals is trending in the right direction. This prediction currently runs until 18.02.27. The prediction end date can be changed by Evercore_Inc_ at any time. Evercore_Inc_ has 50% into this prediction
Performance without dividends (%)
Name 1w
Biocryst Pharmaceuticals 5.27%
iShares Core DAX® 1.066%
iShares Nasdaq 100 -0.493%
iShares Nikkei 225® -2.028%
iShares S&P 500 -0.103%

Comments by Evercore_Inc_ for this prediction

In the thread Biocryst Pharmaceuticals diskutieren
Prediction Buy
Perf. (%) 5.27%
Target price 14.351
Change
Ends at 18.02.27

BioCryst Pharmaceuticals (NASDAQ:BCRX) is now covered by analysts at Evercore Inc. They set an "outperform" rating and a $17.00 price target on the stock.
Ratings data for BCRX provided by MarketBeat